Anti-tumor: IL-33 dependent tumor-infiltrating ILC2s mobilize from lung and facilitate dendritic cells to promote adaptive T cell response. Pro-tumor: IL-33 actives ILC2s to recruit eosinophils through ICOS/ICOSL interaction. This evidence concerns the gene ICOS and neoplasm.